Objectives
Nausea and vomiting of pregnancy (NVP) is a common condition, affecting up to 80% of women in early pregnancy. This module reviews the research and best practices for pharmacologic and non-pharmacologic management of NVP.
By the end of this activity, participants will be able to …
- Summarize the clinical effect of nausea and vomiting of pregnancy
- Diagnose NVP and explain the treatment and management of the condition, including best-practice conservative, pharmacologic, and non-pharmacologic treatments
Physicians can purchase the eModule, access it at the link below, and receive CME credit once they achieve 80% or higher on the posttest. Credit for this ACOG eModule will be available until June 30, 2026.
Credits
ACCME Accreditation
The American College of Obstetricians and Gynecologists is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
AMA PRA Category 1 Credit(s)™
The American College of Obstetricians and Gynecologists designates this enduring material for a maximum of 7 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
College Cognate Credit(s)
The American College of Obstetricians and Gynecologists designates this enduring material for a maximum of 7 Category 1 College Cognate Credits. The College has a reciprocity agreement with the AMA that allows AMA PRA Category 1 Credits™ to be equivalent to College Cognate Credits.
Conflict of Interest Disclosure
The faculty, committee members, and staff who are in position to control the content of this activity are required to disclose to ACOG and to learners any financial relationship(s) of the individual that have occurred within the last 24 months with any ineligible entities whose products are related to the continuing education content. Financial relationships are defined by remuneration in any amount from the ineligible entities in the form of grants; research support; consulting fees; salary; ownership interest (e.g., stocks, stock options, or ownership interest excluding diversified mutual funds); honoraria or other payments for participation in speakers’ bureaus, advisory boards, or boards of directors; or other financial benefits. The intent of this disclosure is not to prevent planners with relevant financial relationships from planning or delivering content, but rather to provide learners with information that allows them to make their own judgments of whether these financial relationships may have influenced the educational activity with regard to exposition or conclusion. ACOG has reviewed all disclosures and resolved or managed all identified conflicts of interest, as applicable.